AZGP1 and obesity disorder: Changes in ZAG levels are closely related to obesity [122] and the associated comorbidities such as diabetes, obesity, polycystic ovary syndrome [123,124], non-alcoholic fatty acid liver disease (NAFLD), etc. [125].